A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation.
Andersson BS, Thall PF, Ma J, Valdez BC, Bassett R Jr, Chen J, Ahmed S, Alousi A, Bashir Q, Ciurea S, Gulbis A, Cool R, Kawedia J, Hosing C, Kebriaei P, Kornblau S, Myers A, Oran B, Rezvani K, Shah N, Shpall E, Parmar S, Popat UR, Nieto Y, Champlin RE.
Andersson BS, et al. Among authors: cool r.
Bone Marrow Transplant. 2022 Aug;57(8):1295-1303. doi: 10.1038/s41409-022-01705-7. Epub 2022 May 24.
Bone Marrow Transplant. 2022.
PMID: 35610308
Free PMC article.
Clinical Trial.